4-aminopyridine has been researched along with Lymphoma, Large-Cell, Anaplastic in 1 studies
Lymphoma, Large-Cell, Anaplastic: A systemic, large-cell, non-Hodgkin, malignant lymphoma characterized by cells with pleomorphic appearance and expressing the CD30 ANTIGEN. These so-called hallmark cells have lobulated and indented nuclei. This lymphoma is often mistaken for metastatic carcinoma and MALIGNANT HISTIOCYTOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Michellys, PY | 1 |
| Chen, B | 1 |
| Jiang, T | 1 |
| Jin, Y | 1 |
| Lu, W | 1 |
| Marsilje, TH | 1 |
| Pei, W | 1 |
| Uno, T | 1 |
| Zhu, X | 1 |
| Wu, B | 1 |
| Nguyen, TN | 1 |
| Bursulaya, B | 1 |
| Lee, C | 1 |
| Li, N | 1 |
| Kim, S | 1 |
| Tuntland, T | 1 |
| Liu, B | 1 |
| Sun, F | 1 |
| Steffy, A | 1 |
| Hood, T | 1 |
1 other study available for 4-aminopyridine and Lymphoma, Large-Cell, Anaplastic
| Article | Year |
|---|---|
Design and synthesis of novel selective anaplastic lymphoma kinase inhibitors.
Topics: 4-Aminopyridine; Anaplastic Lymphoma Kinase; Animals; Antineoplastic Agents; Binding Sites; Cell Lin | 2016 |